Israeli biotech Rosetta Genomics boosted its molecular diagnostics capability by purchasing PersonalizeDx in the United States. Rosetta also received US patent protection for its cancer tests.

http://www.businesswire.com/news/home/20150414005159/en/Rosetta-Genomics-Completes-Acquisition-PersonalizeDx#.VVzo8VIpqSp   http://www.businesswire.com/news/home/20150513005723/en/Rosetta-Genomics-Receives-Additional-U.S.-Patent-Protection#.VVzpr1IpqSp